Naspers Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Naspers Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10235
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:メディア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Naspers Limited – Strategy, SWOT and Corporate Finance Report
Summary

Naspers Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Naspers Limited (Naspers) is a global internet and entertainment group involved in providing of internet services, especially ecommerce, video entertainment and media. It operates various Internet platforms to provide various services and products, including ecommerce, communication, social networks, entertainment, and mobile value-added services. The company also offers digital satellite and digital terrestrial television services to subscribers; mobile and Internet services; subscription video on-demand services; and digital content management and protection systems to protect, manage, and monetize digital media on various platforms. Naspers performs its operations through its subsidiaries and offices spread across Africa, China, Latin America, Central and Eastern Europe, Russia, India, Southeast Asia and the Middle East. It is headquartered in Cape Town, South Africa.

Scope

- Detailed information on Naspers Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Naspers Limited in the form of a SWOT analysis
- An in-depth view of the business model of Naspers Limited including a breakdown and examination of key business segments
- Intelligence on Naspers Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Naspers Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Naspers Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Naspers Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Naspers Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Naspers Limited: Company Overview 9
Naspers Limited: Overview and Key Facts 9
Naspers Limited: Overview 9
Naspers Limited: Key Facts 9
Naspers Limited: Key Employees 11
Naspers Limited: Key Employee Biographies 13
Naspers Limited: Major Products and Services 20
Naspers Limited: Company History 22
Naspers Limited: Management Statement 26
Naspers Limited: Locations and Subsidiaries 32
Naspers Limited: Key Competitors 34
Naspers Limited: Company Analysis 35
Naspers Limited: Business Description 35
Naspers Limited: SWOT Analysis 37
Naspers Limited: SWOT Overview 37
Naspers Limited: Strengths 37
Naspers Limited: Weaknesses 39
Naspers Limited: Opportunities 39
Naspers Limited: Threats 40
Naspers Limited: Corporate Financial Deals Activity 41
Naspers Limited: Financial Deals Overview 41
Naspers Limited: Targets and Partners 43
Naspers Limited: Top Deals 2014 – 2018YTD* 46
Naspers Limited: Advisors 47
Naspers Limited: Top Legal Advisors 47
Naspers Limited: Top Financial Advisors 47
Naspers Limited: Mergers and Acquisitions 48
Naspers Limited: Corporate Venturing 49
Naspers Limited: Divestments 50
Naspers Limited: Recent Developments 51
Naspers Limited: News and Events Summary 51
Naspers Limited: Business Expansion 55
Naspers Limited: Business Reorganization 55
Naspers Limited: Corporate Governance 56
Naspers Limited: Financial Deals 56
Naspers Limited: Financial Performance 56
Naspers Limited: IT Spending Announcements 57
Naspers Limited: Red Flags/Distress Signals 58
Naspers Limited: Red Flags/DistressSignals 58
Naspers Limited: Strategy and Operations 58
Appendix 60
Contact Us 60
Methodology 60
About MarketLine 61

List of Tables
Table 1: Naspers Limited: Key Facts
Table 2: Naspers Limited: Key Employees
Table 3: Naspers Limited: Company History
Table 4: Naspers Limited: Locations and Subsidiaries
Table 5: Naspers Limited: Key Competitors
Table 6: Naspers Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Naspers Limited: M&A Activity by Geography (TTM*)
Table 8: Naspers Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Naspers Limited: M&A Average Deal Size - Value (US$m)
Table 10: Naspers Limited: Targets and Partners
Table 11: Naspers Limited: Top Deals 2014 - 2018YTD*
Table 12: Naspers Limited: Legal Advisor Ranking by Value (US$m)
Table 13: Naspers Limited: Financial Advisor Ranking by Value (US$m)
Table 14: Naspers Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Naspers Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Naspers Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 17: Naspers Limited: Corporate Venturing by Geography (2014 - YTD*2018)
Table 18: Naspers Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Naspers Limited: Divestments by Geography (2014 - YTD*2018)
Table 20: Naspers Limited: News and Events Summary
Table 21: Naspers Limited: Business Expansion
Table 22: Naspers Limited: Business Reorganization
Table 23: Naspers Limited: Corporate Governance
Table 24: Naspers Limited: Financial Deals
Table 25: Naspers Limited: Financial Performance
Table 26: Naspers Limited: IT Spending Announcements
Table 27: Naspers Limited: Red Flags/Distress Signals
Table 28: Naspers Limited: Red Flags/DistressSignals
Table 29: Naspers Limited: Strategy and Operations

List of Figures
Figure 1: Naspers Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Naspers Limited: M&A Activity by Geography (TTM*)
Figure 3: Naspers Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Naspers Limited: M&A Average Deal Size - Value (US$m)
Figure 5: Naspers Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Naspers Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Naspers Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Naspers Limited: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Naspers Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Naspers Limited: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Naspers Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Strategic Resources Inc. (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc. (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Oaks Hotels & Resorts Limited:企業の戦略・SWOT・財務分析
    Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report Summary Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Oaktree Capital Group Llc:企業の戦略・SWOT・財務分析
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SPIE SA (SPIE):企業の財務・戦略的SWOT分析
    SPIE SA (SPIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Bureau Veritas SA (BVI):企業の財務・戦略的SWOT分析
    Bureau Veritas SA (BVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Greenpower Energy Ltd (GPP):石油・ガス:M&Aディール及び事業提携情報
    Summary Greenpower Energy Ltd (Greenpower) is an oil and gas, and mineral exploration and development company. The company’s business activities include acquisition, exploration, and development of petroleum, mineral and hydrothermal exploration properties. It explores for coal, lithium, tantalum, p …
  • Rush Enterprises, Inc. (RUSHA):企業の財務・戦略的SWOT分析
    Rush Enterprises, Inc. (RUSHA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tri Chemical Laboratories, Inc. (4369):企業の財務・戦略的SWOT分析
    Tri Chemical Laboratories, Inc. (4369) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Gentiva Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gentiva Health Services Inc (Gentiva), a subsidiary of Kindred Healthcare Inc is a provider of home health and hospice services. It offers various patient care services at the patient’s home or hospital. Its major services include expert nursing care; disease and pain management; medication …
  • Applus Services, S.A.:企業のM&A・事業提携・投資動向
    Applus Services, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Applus Services, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Randox Laboratories Ltd-医療機器分野:企業M&A・提携分析
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Alamos Gold Inc.:企業の戦略・SWOT・財務情報
    Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Altimmune Inc (ALT):製薬・医療:M&Aディール及び事業提携情報
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is an immunotherapeutics company that develops vaccines and other biological products. The company’s products include nasovax, an intranasally administered recombinant influenza vaccine; and heptcell, an immunotherapy for patients chronically inf …
  • New Zealand Energy Corp (NZ):石油・ガス:M&Aディール及び事業提携情報
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • Diasome Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Diasome Pharmaceuticals Inc (Diasome) is a pharmaceutical company that focusses on clinical and commercial development of therapies for diabetes and obesity. The company offers products in the fields of cell receptor targeting, insulin replacement, and hepatic (liver) glucose metabolism. Its …
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. Te …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆